Instil Bio, Inc.
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Sep 2023 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $2.9M | $7.3M | $8.5M | $42.6M | $29.1M | $21.2M | $14.4M | $10.2M |
| SG&A Expense | $10.7M | $12.4M | $11.9M | $11.2M | $14.0M | $14.2M | $9.0M | $7.2M |
| Operating Income | $-14.1M | $-24.0M | $-66.7M | $-53.8M | $-43.0M | $-35.4M | $-23.4M | $-17.5M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | $2.0M | $2.0M | — | $0 | $0 | — | — |
| Pretax Income | — | — | $-67.4M | $-54.3M | $-43.7M | $-35.5M | $-23.3M | $-17.0M |
| Income Tax Expense | — | — | $0 | $1.1M | $-658.0K | $-159.0K | $-204.0K | $151.0K |
| Net Income | $-14.9M | $-24.3M | $-67.4M | $-55.4M | $-43.0M | $-35.3M | $-23.1M | $-17.2M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-2.29 | $-3.74 | $-10.37 | $-0.22 | $-0.05 | $-0.04 | $-0.09 | $-0.15 |
| EPS (Diluted) | $-2.29 | $-3.74 | $-10.37 | $-0.22 | $-0.05 | $-0.04 | $-0.09 | $-0.15 |
| Shares Outstanding (Basic) | 6.5M | 6.5M | 6.5M | 106.0M | 901.6M | 901.2M | 244.8M | 112.0M |
| Shares Outstanding (Diluted) | 6.5M | 6.5M | 6.5M | 106.0M | 901.6M | 901.2M | 244.8M | 112.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |